Annual Shareholders Equity
$539.11 M
+$222.78 M+70.43%
December 31, 2023
Summary
- As of February 22, 2025, CRNX annual stockholders equity is $539.11 million, with the most recent change of +$222.78 million (+70.43%) on December 31, 2023.
- During the last 3 years, CRNX annual shareholders equity has risen by +$370.19 million (+219.15%).
- CRNX annual shareholders equity is now at all-time high.
Performance
CRNX Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$832.98 M
+$2.22 M+0.27%
September 30, 2024
Summary
- As of February 22, 2025, CRNX quarterly stockholders equity is $832.98 million, with the most recent change of +$2.22 million (+0.27%) on September 30, 2024.
- Over the past year, CRNX quarterly shareholders equity has increased by +$285.23 million (+52.07%).
- CRNX quarterly shareholders equity is now -4.79% below its all-time high of $874.93 million, reached on March 31, 2024.
Performance
CRNX Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
CRNX Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +70.4% | +52.1% |
| 3 y3 years | +219.2% | +52.1% |
| 5 y5 years | +236.5% | +52.1% |
CRNX Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +70.4% | -4.8% | +227.8% |
| 5 y | 5-year | at high | +360.2% | -4.8% | +668.2% |
| alltime | all time | at high | +3688.8% | -4.8% | +3408.5% |
Crinetics Pharmaceuticals Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $832.98 M(+0.3%) |
| Jun 2024 | - | $830.76 M(-5.0%) |
| Mar 2024 | - | $874.93 M(+62.3%) |
| Dec 2023 | $539.11 M(+70.4%) | $539.11 M(-1.6%) |
| Sep 2023 | - | $547.75 M(+115.6%) |
| Jun 2023 | - | $254.12 M(-9.4%) |
| Mar 2023 | - | $280.33 M(-11.4%) |
| Dec 2022 | $316.33 M(-4.7%) | $316.33 M(-10.0%) |
| Sep 2022 | - | $351.37 M(-9.0%) |
| Jun 2022 | - | $386.17 M(+27.4%) |
| Mar 2022 | - | $303.04 M(-8.7%) |
| Dec 2021 | $331.94 M | $331.94 M(+71.5%) |
| Sep 2021 | - | $193.59 M(-3.9%) |
| Jun 2021 | - | $201.44 M(+34.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2021 | - | $149.48 M(-11.5%) |
| Dec 2020 | $168.92 M(+44.2%) | $168.92 M(-9.8%) |
| Sep 2020 | - | $187.22 M(-7.7%) |
| Jun 2020 | - | $202.77 M(+87.0%) |
| Mar 2020 | - | $108.44 M(-7.4%) |
| Dec 2019 | $117.14 M(-26.9%) | $117.14 M(-9.6%) |
| Sep 2019 | - | $129.52 M(-8.9%) |
| Jun 2019 | - | $142.10 M(-6.8%) |
| Mar 2019 | - | $152.39 M(-4.9%) |
| Dec 2018 | $160.22 M(-1166.6%) | $160.22 M(-4.4%) |
| Sep 2018 | - | $167.52 M(-765.4%) |
| Jun 2018 | - | -$25.18 M(+26.0%) |
| Mar 2018 | - | -$19.98 M(+33.0%) |
| Dec 2017 | -$15.02 M(+142.1%) | -$15.02 M |
| Dec 2016 | -$6.20 M | - |
FAQ
- What is Crinetics Pharmaceuticals annual stockholders equity?
- What is the all time high annual shareholders equity for Crinetics Pharmaceuticals?
- What is Crinetics Pharmaceuticals annual shareholders equity year-on-year change?
- What is Crinetics Pharmaceuticals quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Crinetics Pharmaceuticals?
- What is Crinetics Pharmaceuticals quarterly shareholders equity year-on-year change?
What is Crinetics Pharmaceuticals annual stockholders equity?
The current annual shareholders equity of CRNX is $539.11 M
What is the all time high annual shareholders equity for Crinetics Pharmaceuticals?
Crinetics Pharmaceuticals all-time high annual stockholders equity is $539.11 M
What is Crinetics Pharmaceuticals annual shareholders equity year-on-year change?
Over the past year, CRNX annual stockholders equity has changed by +$222.78 M (+70.43%)
What is Crinetics Pharmaceuticals quarterly stockholders equity?
The current quarterly shareholders equity of CRNX is $832.98 M
What is the all time high quarterly shareholders equity for Crinetics Pharmaceuticals?
Crinetics Pharmaceuticals all-time high quarterly stockholders equity is $874.93 M
What is Crinetics Pharmaceuticals quarterly shareholders equity year-on-year change?
Over the past year, CRNX quarterly stockholders equity has changed by +$285.23 M (+52.07%)